(MENAFN) The number of pharmaceutical industrial plants in the UAE is predicted to increase further in the coming five years to 34 percent from 16 recently as part of economic expand.
Accordingly, three deals are expected this year between international drug firms and local producers for manufacturing medicines in the UAE.
In addition, Dubai-bases Global Pharma united Sanofi in a business to produce some of its generic medicines in the UAE, and it entered a deal with Pfizer's Wyeth.
Moreover, the whole healthcare spending in the UAE forecasted to reach USD 19.23bn, an annual increase rate of 7.9 percent, from USD 14.64bn a year earlier.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.